Solve Therapeutics
Antibody-drug conjugate (ADC) linker platform that improves stability and tolerability of cancer therapeutics
- Sector
- Biotech
- Founded
- 2021
- Latest Form D
- $48.2M, Nov 2025
- Total capital
- $162M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $162M
- 3 Form D · last Nov 2025
- 11 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 39 pending · first 2026
- Rank in peer group#481 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 3rd filing$48.2M
- Private capital raisedForm D · SEC · 2nd filing$50.4M
- Private capital raisedForm D · SEC · 1st filing$63.5M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#481 · top 33%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Alan ColowickDirectorNamed in SEC Form D filings
- Clayton D. KnoxExecutive OfficerNamed in SEC Form D filings
- Clayton D. KnoxExecutive OfficerNamed in SEC Form D filings
- Daniel McHughDirectorNamed in SEC Form D filings
- David JohnsonExecutive Officer, DirectorNamed in SEC Form D filings
- Jason PittsDirectorNamed in SEC Form D filings
Show all 9 people
- Langdon MillerExecutive OfficerNamed in SEC Form D filings
- Peter ColabuonoDirectorNamed in SEC Form D filings
- Robert MittendorffDirectorNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 40- PendingCompositions And Uses ThereofUSPTOApplication 19122045
- PendingCompositions And Uses ThereofUSPTOApplication 19115158
- GrantedPTK7-Binding ProteinsUSPTOUS 12,534,529
Show all 40 patent records
- Compositions And Uses ThereofMay 28, 2026 · Application 19122045Pending
- Compositions And Uses ThereofApr 16, 2026 · Application 19115158Pending
- PTK7-Binding ProteinsJan 27, 2026 · US 12,534,529Granted
- ANTI-ROR2 Antibody-drug ConjugatesJan 8, 2026 · Application 19260021Pending
- 5T4-BINDING ProteinsJan 8, 2026 · Application 19257097Pending
- Conjugates And Uses ThereofApplication PCTUS2025048138Pending
- Conjugates And Uses ThereofApplication 63881212Pending
- Conjugates And Uses ThereofApplication PCTUS2025036513Pending
- ANTI-ROR2 Antibody-radionuclide ConjugatesApplication PCTUS2025036490Pending
- ANTI-ROR2 Antibody-drug ConjugatesApplication PCTUS2025036434Pending
- 5T4-BINDING ProteinsApplication PCTUS2025036132Pending
- Conjugates And Uses ThereofApplication 63824757Pending
- Conjugates And Uses ThereofApplication 63824676Pending
- Conjugates And Uses ThereofApplication PCTUS2025026903Pending
- Conjugates And Uses ThereofApplication PCTUS2025025244Pending
- Conjugates And Uses ThereofApplication 63785535Pending
- 5T4-BINDING ProteinsApplication 63743001Pending
- Conjugates And Uses ThereofApplication 63723081Pending
- Conjugates And Uses ThereofApplication 63723077Pending
- Conjugates And Uses ThereofApplication 63722553Pending
- Conjugates And Uses ThereofApplication PCTUS2026015467Pending
- Conjugates And Uses ThereofApplication PCTUS2026015465Pending
- Conjugates And Uses ThereofApplication PCTUS2026015280Pending
- Conjugates And Uses ThereofApplication PCTUS2026014667Pending
- Conjugates And Uses ThereofApplication PCTUS2026014648Pending
- Conjugates And Uses ThereofApplication 19492816Pending
- Conjugates And Uses ThereofApplication 19485255Pending
- Compositions And Uses ThereofApplication 19115167Pending
- Conjugates And Uses ThereofApplication 63760036Pending
- Conjugates And Uses ThereofApplication 63760033Pending
- Conjugates And Uses ThereofApplication 63758846Pending
- Conjugates And Uses ThereofApplication 63757698Pending
- Conjugates And Uses ThereofApplication 63757681Pending
- PTK7-Binding ProteinsApplication 63722437Pending
- Conjugates And Uses ThereofApplication 63722552Pending
- Conjugates And Uses ThereofApplication 63707693Pending
- Conjugates And Uses ThereofApplication 63707680Pending
- Conjugates And Uses ThereofApplication 63700544Pending
- Conjugates And Uses ThereofApplication 63700539Pending
- Conjugates And Uses ThereofApplication 63668058Pending
Related companies, and why
- LIGHT SWITCH BIO, LLCSimilar federal contract value in Biotech · null in contracts
- Artiva BiotherapeuticsSimilar federal contract value in Biotech · null in contracts
- Verastem, Inc.Similar federal contract value in Biotech · null in contracts
- Andira Medicine Inc.Similar federal contract value in Biotech · null in contracts
- OnKure TherapeuticsSimilar federal contract value in Biotech · null in contracts
- TORL BioTherapeuticsSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .